{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:21:00Z","timestamp":1787746860431,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573210"],"award-info":[{"award-number":["82573210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024MH095"],"award-info":[{"award-number":["ZR2024MH095"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2021LSW004"],"award-info":[{"award-number":["ZR2021LSW004"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pan.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:42:03Z","timestamp":1786059723000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intratumoral microbiota in pancreatic neuroendocrine tumors: Enriched bacterial biomass and diversity with association to dyslipidemia"],"prefix":"10.1016","author":[{"given":"Yu-Fan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8663-2783","authenticated-orcid":false,"given":"Han-Xiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pan.2026.08.004_bib1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/ijms25021331","article-title":"Pancreatic neuroendocrine tumors: signaling pathways and epigenetic regulation","volume":"25","author":"Saleh","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.pan.2026.08.004_bib2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40618-022-01985-2","article-title":"The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States","volume":"46","author":"Liu","year":"2022","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.pan.2026.08.004_bib3","article-title":"Epigenomic heterogeneity of non-functional pancreatic neuroendocrine tumors uncovered by single nucleus and spatial ATAC profiling","author":"Wang","year":"2025","journal-title":"bioRxiv"},{"issue":"7643","key":"10.1016\/j.pan.2026.08.004_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pan.2026.08.004_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.semcancer.2021.05.027","article-title":"A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma","volume":"86","author":"Pandya","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"10.1016\/j.pan.2026.08.004_bib6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/SLA.0000000000006299","article-title":"Comprehensive assessment of the intrinsic pancreatic microbiome","volume":"282","author":"Eckhoff","year":"2025","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.pan.2026.08.004_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s43556-025-00248-9","article-title":"Tumor microbiome: roles in tumor initiation, progression, and therapy","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol Biomed"},{"issue":"4","key":"10.1016\/j.pan.2026.08.004_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010365","article-title":"Intratumoral microbiota predicts the response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer","volume":"13","author":"Chen","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"41","key":"10.1016\/j.pan.2026.08.004_bib9","article-title":"Tumor-resident microbiota-based risk model predicts neoadjuvant therapy response of locally advanced esophageal squamous cell carcinoma patients","volume":"11","author":"Wu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"10.1016\/j.pan.2026.08.004_bib10","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nmeth.2604","article-title":"UPARSE: highly accurate OTU sequences from microbial amplicon reads","volume":"10","author":"Edgar","year":"2013","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.pan.2026.08.004_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ismej.2010.133","article-title":"UniFrac: an effective distance metric for microbial community comparison","volume":"5","author":"Lozupone","year":"2011","journal-title":"ISME J"},{"issue":"4","key":"10.1016\/j.pan.2026.08.004_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pan.2026.08.004_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.pan.2026.08.004_bib14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2174\/1568026623666230522103321","article-title":"Aberrant lipid metabolism in cancer: current status and emerging therapeutic perspectives","volume":"23","author":"Irshad","year":"2023","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pan.2026.08.004_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1669544","article-title":"Fueling the fire-a pan-cancer analysis of MYC-regulated lipid metabolism","volume":"13","author":"Chatterjee","year":"2025","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.pan.2026.08.004_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol Cancer"},{"issue":"22","key":"10.1016\/j.pan.2026.08.004_bib17","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.3390\/cells11223595","article-title":"Survival pathways of HIF-deficient tumour cells: TCA inhibition, peroxisomal fatty acid oxidation activation and an AMPK-PGC-1\u03b1 hypoxia sensor","volume":"11","author":"Golinska","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.pan.2026.08.004_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.pan.2026.08.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1194\/jlr.E012138","article-title":"The role of HDL in innate immunity","volume":"52","author":"Feingold","year":"2011","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.pan.2026.08.004_bib20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pan.2026.08.004_bib21","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.pan.2026.08.004_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2249143","article-title":"Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell","volume":"15","author":"Zhu","year":"2023","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.pan.2026.08.004_bib23","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","article-title":"Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer","volume":"11","author":"Coutzac","year":"2020","journal-title":"Nat Commun"},{"issue":"10446","key":"10.1016\/j.pan.2026.08.004_bib24","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","volume":"403","author":"Singh","year":"2024","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.pan.2026.08.004_bib25","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.3390\/ijms26167814","article-title":"Decoding pancreatic neuroendocrine tumors: molecular profiles, biomarkers, and pathways to personalized therapy","volume":"26","author":"Galasso","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.pan.2026.08.004_bib26","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1158\/1535-7163.MCT-22-0798","article-title":"Upregulation of somatostatin receptor type 2 improves 177Lu-DOTATATE therapy in receptor-deficient pancreatic neuroendocrine tumor model","volume":"22","author":"Sharma","year":"2023","journal-title":"Mol Cancer Therapeut"},{"issue":"3","key":"10.1016\/j.pan.2026.08.004_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11307-018-1252-5","article-title":"Pre-therapy somatostatin receptor-based heterogeneity predicts overall survival in pancreatic neuroendocrine tumor patients undergoing peptide receptor radionuclide therapy","volume":"21","author":"Werner","year":"2019","journal-title":"Mol Imag Biol"},{"issue":"10","key":"10.1016\/j.pan.2026.08.004_bib28","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ccell.2022.09.009","article-title":"Tumor microbiome links cellular programs and immunity in pancreatic cancer","volume":"40","author":"Ghaddar","year":"2022","journal-title":"Cancer Cell"},{"issue":"6356","key":"10.1016\/j.pan.2026.08.004_bib29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pan.2026.08.004_bib30","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/2767-9764.CRC-23-0367","article-title":"The tumor microbiome reacts to hypoxia and can influence response to radiation treatment in colorectal cancer","volume":"4","author":"Benej","year":"2024","journal-title":"Cancer Res Commun"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326008744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326008744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:44:27Z","timestamp":1787744667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390326008744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S1424390326008744"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2026.08.004","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratumoral microbiota in pancreatic neuroendocrine tumors: Enriched bacterial biomass and diversity with association to dyslipidemia","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}